chr19-17844194-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000215.4(JAK3):c.184+40G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.32 in 1,539,842 control chromosomes in the GnomAD database, including 85,444 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.42 ( 15594 hom., cov: 32)
Exomes 𝑓: 0.31 ( 69850 hom. )
Consequence
JAK3
NM_000215.4 intron
NM_000215.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.74
Genes affected
JAK3 (HGNC:6193): (Janus kinase 3) The protein encoded by this gene is a member of the Janus kinase (JAK) family of tyrosine kinases involved in cytokine receptor-mediated intracellular signal transduction. It is predominantly expressed in immune cells and transduces a signal in response to its activation via tyrosine phosphorylation by interleukin receptors. Mutations in this gene are associated with autosomal SCID (severe combined immunodeficiency disease). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 19-17844194-C-T is Benign according to our data. Variant chr19-17844194-C-T is described in ClinVar as [Benign]. Clinvar id is 1291546.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.692 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
JAK3 | NM_000215.4 | c.184+40G>A | intron_variant | ENST00000458235.7 | NP_000206.2 | |||
JAK3 | XM_047438786.1 | c.184+40G>A | intron_variant | XP_047294742.1 | ||||
JAK3 | XM_011527991.3 | c.184+40G>A | intron_variant | XP_011526293.2 | ||||
JAK3 | XR_007066796.1 | n.234+40G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
JAK3 | ENST00000458235.7 | c.184+40G>A | intron_variant | 5 | NM_000215.4 | ENSP00000391676.1 |
Frequencies
GnomAD3 genomes AF: 0.416 AC: 63238AN: 151832Hom.: 15562 Cov.: 32
GnomAD3 genomes
AF:
AC:
63238
AN:
151832
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.333 AC: 54007AN: 162192Hom.: 9739 AF XY: 0.327 AC XY: 28287AN XY: 86562
GnomAD3 exomes
AF:
AC:
54007
AN:
162192
Hom.:
AF XY:
AC XY:
28287
AN XY:
86562
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.309 AC: 429415AN: 1387892Hom.: 69850 Cov.: 28 AF XY: 0.309 AC XY: 211770AN XY: 686182
GnomAD4 exome
AF:
AC:
429415
AN:
1387892
Hom.:
Cov.:
28
AF XY:
AC XY:
211770
AN XY:
686182
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.417 AC: 63319AN: 151950Hom.: 15594 Cov.: 32 AF XY: 0.412 AC XY: 30622AN XY: 74288
GnomAD4 genome
AF:
AC:
63319
AN:
151950
Hom.:
Cov.:
32
AF XY:
AC XY:
30622
AN XY:
74288
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1290
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 23, 2018 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 61% of patients studied by a panel of primary immunodeficiencies. Number of patients: 54. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at